Q-omics provides the consensus-scored LCN1P2 profile across patient tissues and cancer cell-line models. LCN1P2 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in TGCT. Additionally, LCN1P2 RNA expression shows 6,681 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight TGCT, and THYM as cancer lineages where LCN1P2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.